NeoGenomics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.About NEO
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T.
CEOAnthony P. Zook
CEOAnthony P. Zook
Employees2,200
Employees2,200
HeadquartersFort Myers, Florida
HeadquartersFort Myers, Florida
Founded1998
Founded1998
Employees2,200
Employees2,200
NEO Key Statistics
Market cap1.31B
Market cap1.31B
Price-Earnings ratio-12.60
Price-Earnings ratio-12.60
Dividend yield—
Dividend yield—
Average volume6.13M
Average volume6.13M
High today$10.38
High today$10.38
Low today$9.20
Low today$9.20
Open price$10.08
Open price$10.08
Volume1.69M
Volume1.69M
52 Week high$19.12
52 Week high$19.12
52 Week low$4.72
52 Week low$4.72
NEO News
Nasdaq 8h
NEO Crosses Above Average Analyst TargetIn recent trading, shares of NeoGenomics Inc (Symbol: NEO) have crossed above the average analyst 12-month target price of $10.00, changing hands for $10.28/sha...
Nasdaq 1d
NeoGenomics Moves 6.3% Higher: Will This Strength Last?NeoGenomics (NEO) shares soared 6.3% in the last trading session to close at $9.97. The move was backed by solid volume with far more shares changing hands than...
Nasdaq 4d
NEO Crosses Above Key Moving Average LevelIn trading on Monday, shares of NeoGenomics Inc (Symbol: NEO) crossed above their 200 day moving average of $9.36, changing hands as high as $9.62 per share. Ne...
Analyst ratings
53%
of 15 ratingsBuy
40%
Hold
53.3%
Sell
6.7%
People also own
Based on the portfolios of people who own NEO. This list is generated using Robinhood data, and it’s not a recommendation.